Company / Shareholders' Equity
PAVmed Inc. Shareholders' Equity History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$34.0M
FY2025
5-year range
-$53.8M / $61.7M
FY2021-FY2025
Trend
+1461.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +1461% YoY in FY2025, a notable deviation from the 4-year average annual change of +246%.
Based on SEC 10-K filings.
$34M in FY2025.
Improved from -$54M to $34M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shareholders' equity increased 1461.4% year-over-year.
- Peak shareholders' equity was recorded in FY2021.
- Lowest shareholders' equity in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $34.0M | +1461.4% |
| FY2024 | -$2.5M | +95.4% |
| FY2023 | -$53.8M | -456.0% |
| FY2022 | -$9.7M | -115.7% |
| FY2021 | $61.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026